Skip to main content
36°
Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Atara Biotherapeutics, Inc. - Common Stock
(NQ:
ATRA
)
6.890
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 12, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
6.890
Bid (Size)
6.880 (4)
Ask (Size)
7.020 (7)
Prev. Close
6.890
Today's Range
6.890 - 6.890
52wk Range
5.400 - 20.81
Shares Outstanding
101,102,152
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Atara Biotherapeutics Announces Fourth Quarter and Full Year 2024 Financial Results and Operational Progress
March 07, 2025
From
Atara Biotherapeutics, Inc.
Via
Business Wire
Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
February 07, 2025
From
Atara Biotherapeutics, Inc.
Via
Business Wire
Performance
YTD
-51.34%
-51.34%
1 Month
-25.59%
-25.59%
3 Month
-41.36%
-41.36%
6 Month
-17.09%
-17.09%
1 Year
-60.63%
-60.63%
More News
Read More
ATRA Investors Have Opportunity to Join Atara Biotherapeutics, Inc. Securities Fraud Investigation with the Schall Law Firm
January 27, 2025
From
The Schall Law Firm
Via
Business Wire
Earnings Scheduled For November 12, 2024
November 12, 2024
Via
Benzinga
Insights into Atara Biotherapeutics's Upcoming Earnings
November 11, 2024
Via
Benzinga
FDA Places Clinical Hold On Atara Biotherapeutics' Two Cell Therapy Programs
January 21, 2025
Via
Benzinga
Exposures
Product Safety
Atara Biotherapeutics Provides Update on Clinical Programs Related to EBVALLO™ (tabelecleucel) and ATA3219
January 21, 2025
From
Atara Biotherapeutics, Inc.
Via
Business Wire
Nasdaq Down 150 Points; Morgan Stanley Earnings Top Estimates
January 16, 2025
Via
Benzinga
Atara Stock Plunges To 3-Month Low After FDA Blocks Blood Cancer Drug: Retail's Buying The Dip
January 16, 2025
Via
Stocktwits
Exposures
Product Safety
Crude Oil Down 1%; Bank of America Posts Upbeat Earnings
January 16, 2025
Via
Benzinga
Exposures
Fossil Fuels
US Stocks Edge Lower; Retail Sales Increase Less Than Expected
January 16, 2025
Via
Benzinga
Atara Biotherapeutics Provides Regulatory and Business Update on EBVALLOTM (tabelecleucel)
January 16, 2025
From
Atara Biotherapeutics, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 14, 2025
Via
Benzinga
Atara Biotherapeutics to Participate at the 7th Annual Evercore ISI HealthCONx Conference
November 27, 2024
From
Atara Biotherapeutics, Inc.
Via
Business Wire
Atara Biotherapeutics to Participate at the Stifel 2024 Healthcare Conference
November 13, 2024
From
Atara Biotherapeutics, Inc.
Via
Business Wire
Atara Biotherapeutics Announces Third Quarter 2024 Financial Results and Operational Progress
November 12, 2024
From
Atara Biotherapeutics, Inc.
Via
Business Wire
Sidoti Events, LLC's Virtual November Micro-Cap Conference
November 12, 2024
Via
ACCESSWIRE
Atara Biotherapeutics to Announce Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
November 05, 2024
From
Atara Biotherapeutics, Inc.
Via
Business Wire
Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
October 04, 2024
From
Atara Biotherapeutics, Inc.
Via
Business Wire
Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
September 06, 2024
From
Atara Biotherapeutics, Inc.
Via
Business Wire
Atara Biotherapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
September 04, 2024
From
Atara Biotherapeutics, Inc.
Via
Business Wire
Crude Oil Down 1%; Dollar Tree Shares Tumble After Downbeat Earnings
September 04, 2024
Via
Benzinga
Exposures
Fossil Fuels
Atara Biotherapeutics (ATRA) Stock Is Up 20%: What's Going On?
September 04, 2024
Via
Benzinga
Why GitLab Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
September 04, 2024
Via
Benzinga
Atara Biotherapeutics Announces $36 Million Registered Direct Offering
September 03, 2024
From
Atara Biotherapeutics, Inc.
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.